Research Overview
Cagrilintide is a long-acting amylin analog designed for extended receptor engagement in research models. It acts on amylin receptors (CTR/RAMP complexes) and has been studied in combination with GLP-1 agonists for synergistic metabolic pathway research. Applications include amylin receptor pharmacology, satiety signaling research, and dual-agonist combination studies.
Compound Specifications
| Molecular Formula | C₁₈₅H₂₈₄N₄₈O₅₆S₂ |
|---|---|
| Molecular Weight | 4,077.6 Da |
| CAS Number | 2381002-10-2 |
| Sequence | Modified amylin analog sequence with C20 fatty acid chain |
| Purity | >98% (HPLC verified) |
| Storage | Store at -20°C. Stable 24 months lyophilized. |
| Form | Lyophilized powder |
⚠ GLP-1 COMPOUND — ENHANCED COMPLIANCE NOTICE
This compound is a GLP-1 receptor agonist analog. It is subject to heightened regulatory scrutiny. Purchase is restricted to verified research institutions and qualified researchers. This compound is NOT approved for human use and is sold exclusively for in vitro laboratory research. Misuse or diversion for human administration is strictly prohibited and may be unlawful.
This compound is a GLP-1 receptor agonist analog. It is subject to heightened regulatory scrutiny. Purchase is restricted to verified research institutions and qualified researchers. This compound is NOT approved for human use and is sold exclusively for in vitro laboratory research. Misuse or diversion for human administration is strictly prohibited and may be unlawful.
Certificate of Analysis
Each batch is third-party tested. COA available upon request — contact us with your order number.
⚠ RESEARCH USE ONLY — This product is sold exclusively for in vitro laboratory research purposes. It is not intended for human or veterinary use, consumption, injection, or any clinical application. Not for sale to minors. By purchasing, you confirm you are a qualified research professional aged 21 or older.
Reviews
There are no reviews yet.